Translational Research in Pediatric and Obstetric Pharmacology (R01, R03, R21)

Funding Agency:
National Institutes of Health

The purpose of this funding opportunity announcement (FOA) is to encourage applications for translational and clinical research as well as clinical trials that will advance our knowledge about the underlying mechanisms of drug action, response, and safety in children at various developmental stages, and in women during pregnancy and lactation. The overall goals of the FOA are to improve the safety and effectiveness of current drugs for pediatric or obstetric patients, and to enhance the development of new drugs or a safer usage of the existing drugs for tailored therapies to meet emerging clinical needs for these special populations.  

This FOA will utilize the NIH Research Project Grant (R01) mechanism and runs in parallel with FOAs of identical scientific scope: PAR-17-188, which encourages applications under the R03 grant mechanism, and PAR-18-214, which encourages applications under the R21 grant mechanism.


  • Letter of Intent Deadlines: 30 days prior to the applicable receipt date
  • Application Deadlines:  April 4, 2018; August 7, 2018; November 7, 2018; April 4, 2019; August 7, 2019; November 7, 2019; April 3, 2020

PAR-18-215 Expiration Date: April 4, 2020  




Medical - Clinical Science
Medical - Translational

External Deadline

August 7, 2019